Karpel-Massler, G., Horst, B. A., Shu, C., Chau, L., Tsujiuchi, T., Bruce, J. N., . . . Siegelin, M. D. (2016). A synthetic cell-penetrating dominant-negative ATF5 peptide exerts anti-cancer activity against a broad spectrum of treatment resistant cancers. Clin Cancer Res.
Chicago-стиль цитированияKarpel-Massler, Georg, et al. "A Synthetic Cell-penetrating Dominant-negative ATF5 Peptide Exerts Anti-cancer Activity against a Broad Spectrum of Treatment Resistant Cancers." Clin Cancer Res 2016.
MLA-цитированиеKarpel-Massler, Georg, et al. "A Synthetic Cell-penetrating Dominant-negative ATF5 Peptide Exerts Anti-cancer Activity against a Broad Spectrum of Treatment Resistant Cancers." Clin Cancer Res 2016.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.